R J Friedman

Summary

Publications

  1. doi request reprint Limit the bleeding, limit the pain in total hip and knee arthroplasty
    Richard J Friedman
    Department of Orthopedic Surgery, Medical University of South Carolina, USA
    Orthopedics 33:11-3. 2010
  2. ncbi request reprint Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty--insights from the Multinational Global Orthopaedic Registry (GLORY)
    Richard J Friedman
    Charleston Orthopedic Associates, Charleston, SC 29414, USA
    Am J Orthop (Belle Mead NJ) 39:14-21. 2010
  3. doi request reprint Strengths and limitations of standards of care to guide the orthopedic surgeon in VTE prevention
    Richard J Friedman
    Department of Orthopedic Surgery, Medical University of South Carolina, Charleston, South Carolina, USA
    Orthopedics 34:121-8. 2011
  4. pmc New oral anticoagulants for thromboprophylaxis after elective total hip and knee arthroplasty
    Richard J Friedman
    Department of Orthopaedic Surgery, Roper Hospital, Charleston Orthopaedic Associates, 1012 Physicians Drive, Charleston, SC 29414, USA
    Thrombosis 2010:280731. 2010
  5. pmc Simplifying thromboprophylaxis could improve outcomes in orthopaedic surgery
    Richard J Friedman
    Department of Orthopaedic Surgery, Roper Hospital, Charleston Orthopaedic Associates, 1012 Physicians Drive, Charleston, SC 29414, USA
    Thrombosis 2010:108049. 2010
  6. ncbi request reprint Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty
    Richard Friedman
    Department of Orthopaedic Surgery, Medical University of South Carolina, Charleston Orthopaedic Associates, 1012 Physicians Drive, Charleston, SC 29414 E mail address
    J Bone Joint Surg Am 96:272-8. 2014
  7. pmc Complication rates after hip or knee arthroplasty in morbidly obese patients
    Richard J Friedman
    Charleston Orthopaedic Associates, 1012 Physicians Drive, Charleston, SC, 29414, USA
    Clin Orthop Relat Res 471:3358-66. 2013
  8. pmc Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials
    Nadia Rosencher
    Staff Anaesthesiologist, Department of Anaesthesiology and Intensive Care, Paris Descartes University, Cochin Hospital AP HP, rue du Faubourg Saint Jacques, 75014, Paris, France
    Thromb J 10:9. 2012
  9. doi request reprint Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding
    Richard J Friedman
    Department of Orthopedic Surgery, Roper Hospital and Charleston Orthopedic Associates, Charleston, South Carolina 29414, USA
    Thromb Haemost 108:183-90. 2012
  10. doi request reprint Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban
    Richard J Friedman
    Department of Orthopaedic Surgery, Roper Hospital and Medical University of South Carolina, Charleston, SC, USA
    Expert Rev Pharmacoecon Outcomes Res 11:299-306. 2011

Detail Information

Publications16

  1. doi request reprint Limit the bleeding, limit the pain in total hip and knee arthroplasty
    Richard J Friedman
    Department of Orthopedic Surgery, Medical University of South Carolina, USA
    Orthopedics 33:11-3. 2010
    ..This article focuses on intraoperative techniques available to limit bleeding, thereby minimizing pain and the need for postoperative transfusion...
  2. ncbi request reprint Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty--insights from the Multinational Global Orthopaedic Registry (GLORY)
    Richard J Friedman
    Charleston Orthopedic Associates, Charleston, SC 29414, USA
    Am J Orthop (Belle Mead NJ) 39:14-21. 2010
    ..This paper reviews the GLORY practice findings in light of the contemporary literature on best practices for VTE prophylaxis in orthopedic patients...
  3. doi request reprint Strengths and limitations of standards of care to guide the orthopedic surgeon in VTE prevention
    Richard J Friedman
    Department of Orthopedic Surgery, Medical University of South Carolina, Charleston, South Carolina, USA
    Orthopedics 34:121-8. 2011
    ..Improved health care and better outcomes can be achieved for orthopedic surgery patients by considering VTE prophylaxis from the viewpoint of the clinical guidelines and patient-specific factors...
  4. pmc New oral anticoagulants for thromboprophylaxis after elective total hip and knee arthroplasty
    Richard J Friedman
    Department of Orthopaedic Surgery, Roper Hospital, Charleston Orthopaedic Associates, 1012 Physicians Drive, Charleston, SC 29414, USA
    Thrombosis 2010:280731. 2010
    ..Clearly, there is a need for new oral, fixed-dose anticoagulant drugs that do not require coagulation monitoring, while demonstrating similar or better efficacy and safety profiles when compared with current agents...
  5. pmc Simplifying thromboprophylaxis could improve outcomes in orthopaedic surgery
    Richard J Friedman
    Department of Orthopaedic Surgery, Roper Hospital, Charleston Orthopaedic Associates, 1012 Physicians Drive, Charleston, SC 29414, USA
    Thrombosis 2010:108049. 2010
    ..Simplifying therapy with more convenient, efficacious, and safe anticoagulants could change attitudes to anticoagulant use and improve adherence to thromboprophylactic guidelines...
  6. ncbi request reprint Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty
    Richard Friedman
    Department of Orthopaedic Surgery, Medical University of South Carolina, Charleston Orthopaedic Associates, 1012 Physicians Drive, Charleston, SC 29414 E mail address
    J Bone Joint Surg Am 96:272-8. 2014
    ....
  7. pmc Complication rates after hip or knee arthroplasty in morbidly obese patients
    Richard J Friedman
    Charleston Orthopaedic Associates, 1012 Physicians Drive, Charleston, SC, 29414, USA
    Clin Orthop Relat Res 471:3358-66. 2013
    ..Morbid obesity has been shown to be a risk factor for increased complications after THA and TKA; however, large studies that would determine the effect size are lacking...
  8. pmc Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials
    Nadia Rosencher
    Staff Anaesthesiologist, Department of Anaesthesiology and Intensive Care, Paris Descartes University, Cochin Hospital AP HP, rue du Faubourg Saint Jacques, 75014, Paris, France
    Thromb J 10:9. 2012
    ..abstract:..
  9. doi request reprint Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding
    Richard J Friedman
    Department of Orthopedic Surgery, Roper Hospital and Charleston Orthopedic Associates, Charleston, South Carolina 29414, USA
    Thromb Haemost 108:183-90. 2012
    ....
  10. doi request reprint Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban
    Richard J Friedman
    Department of Orthopaedic Surgery, Roper Hospital and Medical University of South Carolina, Charleston, SC, USA
    Expert Rev Pharmacoecon Outcomes Res 11:299-306. 2011
    ..This brief article outlines such potential savings with rivaroxaban based on the results of the REgulation of Coagulation in ORthopaedic surgery to prevent Deep vein thrombosis and pulmonary embolism (RECORD) program...
  11. doi request reprint Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials
    R J Friedman
    Medical University of South Carolina and Charleston Orthopedic Associates, Charleston, South Carolina 29414, USA
    Thromb Res 126:175-82. 2010
    ..Three randomized, double-blind trials compared dabigatran, an oral direct thrombin inhibitor, with enoxaparin for the primary prevention of venous thromboembolism (VTE) in patients undergoing elective total hip and knee arthroplasty...
  12. ncbi request reprint Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty
    Richard J Friedman
    Charleston Orthopedic Associates, Charleston, SC 29414, USA
    Curr Med Res Opin 24:87-97. 2008
    ..Our objective was to analyze data from the multinational Global Orthopaedic Registry (GLORY) to evaluate the compliance of surgeons with the American College of Chest Physicians (ACCP) guidelines for VTE prevention...
  13. doi request reprint New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty
    Richard J Friedman
    Department of Orthopaedic Surgery, Roper Hospital, and Department of Orthopaedic Surgery, Medical University of South Carolina, Charleston, South Carolina, USA
    Orthopedics 32:79-84. 2009
    ..These new oral agents have shown efficacy in large randomized clinical trials and offer new, more convenient options for anticoagulation...
  14. ncbi request reprint Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty
    Richard J Friedman
    Medical University of South Carolina, Charleston, USA
    J Am Acad Orthop Surg 15:148-55. 2007
    ..Using weighted risk factors to assess individual risk for venous thromboembolism can help the physician determine the optimal duration of prophylaxis...
  15. doi request reprint Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty
    Bengt I Eriksson
    Sahlgrenska University Hospital Ostra, Gothenburg, Sweden
    N Engl J Med 358:2765-75. 2008
    ..This phase 3 trial compared the efficacy and safety of rivaroxaban, an oral direct inhibitor of factor Xa, with those of enoxaparin for extended thromboprophylaxis in patients undergoing total hip arthroplasty...
  16. pmc Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty
    Bengt I Eriksson
    Clin Orthop Relat Res 466:2009-11; author reply 2012-4. 2008